form13ga.htm
OMB APPROVAL
OMB Number: 3235-0145
Expires: February 28, 2009
Estimated average burden
Hours per response 10.4


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)*


Bio-Imaging Technologies, Inc.
-------------------------------------------------------------------------------
(Name of Issuer)

Common Stock
-------------------------------------------------------------------------------
(Title of Class of Securities)


09056N103
----------------------------------------
(CUSIP Number)


July 2, 2007
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[_] Rule 13d-1(b)

[X] Rule 13d-1(c)

[_] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMD control number.

SEC 1745 (3-06)

Page 1 of  6 pages
 


------------------------------------------------
CUSIP No. 09056N103
------------------------------------------------
 
---------------------------------------------------------------------------------------------------------------------------------
1    Name of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
 
Healthinvest Partners AB
 
---------------------------------------------------------------------------------------------------------------------------------
2    Check the Appropriate Box if a Member of a Group (See Instruction)
 
(a) [ ]
(b) [X]
 
---------------------------------------------------------------------------------------------------------------------------------
3   SEC Use Only
 
---------------------------------------------------------------------------------------------------------------------------------
 
4    Citizen or Place of Organization
 
Sweden
 
---------------------------------------------------------------------------------------------------------------------------------
Number of    5    Sole Voting Power        578,678
------------------------------------------------------------------------------------------------------------
Shares
 
Beneficially   6    Shared Voting Power          0
-----------------------------------------------------------------------------------------------------------
Owned by
 
Each       7    Sole Dispositive Power       578,678
------------------------------------------------------------------------------------------------------------
Reporting
 
Person With:      8    Shared Dispositive Power         0
---------------------------------------------------------------------------------------------------------------------------------
 
9           Aggregate Amount Beneficially Owned by Each Reporting Person
 
    578,678
---------------------------------------------------------------------------------------------------------------------------------
10         Check if the Aggregate Amount in Row (9) Excludes Certain Shares
 (See Instructions)       [ ]
---------------------------------------------------------------------------------------------------------------------------------
11          Percent of Class Represented by Amount in Row (9)
 
              4.9%
---------------------------------------------------------------------------------------------------------------------------------
12          Type of Reporting Person (See Instructions)
 
  IA, HC
---------------------------------------------------------------------------------------------------------------------------------


Page 2 of  6 pages
 


------------------------------------------------
CUSIP No. 09056N103
------------------------------------------------
 
---------------------------------------------------------------------------------------------------------------------------------
1    Name of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
 
HealthInvest Global Long/Short Fund
 
---------------------------------------------------------------------------------------------------------------------------------
2    Check the Appropriate Box if a Member of a Group (See Instruction)
 
(a) [ ]
(b) [X]
 
---------------------------------------------------------------------------------------------------------------------------------
3    SEC Use Only
 
---------------------------------------------------------------------------------------------------------------------------------
 
4    Citizen or Place of Organization
 
Sweden
 
---------------------------------------------------------------------------------------------------------------------------------
Number of    5     Sole Voting Power             0
------------------------------------------------------------------------------------------------------------
Shares
 
Beneficially   6    Shared Voting Power        578,678
-----------------------------------------------------------------------------------------------------------
Owned by
 
Each       7     Sole Dispositive Power          0
------------------------------------------------------------------------------------------------------------
Reporting
 
Person With:       8      Shared Dispositive Power       578,678
---------------------------------------------------------------------------------------------------------------------------------
 
9   Aggregate Amount Beneficially Owned by Each Reporting Person
 
578,678
---------------------------------------------------------------------------------------------------------------------------------
10       Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)       [ ]
---------------------------------------------------------------------------------------------------------------------------------
11       Percent of Class Represented by Amount in Row (9)
 
4.9%
---------------------------------------------------------------------------------------------------------------------------------
12       Type of Reporting Person (See Instructions)
 
OO
---------------------------------------------------------------------------------------------------------------------------------


Page 3 of  6 pages
 


Item 1(a)
Name of Issuer
 
Bio-Imaging Technologies, Inc.
   
Item 1(b)
Address of Issuers Principal Executive Offices:
 
826 Newtown-Yardley Road
 
Newtown, Pennsylvania 18940-1721
   
Item 2(a)
Name of Persons Filing:
 
Healthinvest Partners AB and HealthInvest Global Long/Short Fund
 
Healthinvest Partners AB is the investment advisor and control person of HealthInvest Global Long/Short Fund, a security holder of the issuer. HealthInvest Global Long/Short Fund is a specialty fund organized pursuant to the Swedish Mutual Funds Act.
   
Item 2(b)
Address of Principal Business Office or, Residence:
 
Arsenalsgatan 4
 
SE-111 47 Stockholm
 
Sweden
   
Item 2(c)
Citizenship:
 
See the response(s) to Item 4 on the attached cover page(s).
   
Item 2(d)
Title of Class of Securities:
 
Common Stock
   
Item 2(e)
CUSIP Number:
 
09056N103
   
Item 3
If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:
 
Not Applicable


Page 4 of  6 pages
 


 
Item 4           Ownership
 
(a)        Amount Beneficially owned:
See the response(s) to Item 9 on the attached cover page(s).
 
(b)        Percent of Class:
See the response(s) to Item 11 on the attached cover page(s).
 
(c)        Number of shares as to which the person has:
 
(i)   Sole power to vote or to direct the vote:
See the response(s) to Item 5 on the attached cover page(s).
 
(ii)        Shared power to vote or to direct the vote:
See the response(s) to Item 6 on the attached cover page(s).
 
(iii)       Sole power to dispose or direct the disposition of:
See the response(s) to Item 7 on the attached cover page(s).
 
(iv)       Shared power to dispose or direct the disposition of:
See the response(s) to Item 8 on the attached cover page(s).
 
Item 5             Ownership of five percent or less of a class.
       If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial            
            owner of more than five percent of the class of securities, check the following [X]. 
 
Item 6             Ownership of more than five percent on behalf of another person.
Not Applicable
 
Item 7             Identification and Classification of the Subsidiary which acquired the Security
being reported by the Parent Holding Company.
Not Applicable
 
Item 8              Identification and Classification of Members of the Group.
Not Applicable
 
Item 9             Notice of Dissolution of Group.
Not Applicable
 
Item 10           Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


Page 5 of  6 pages
 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


DATE:    July 10, 2007
                    HEALTHINVEST PARTNERS AB
 
                    By: /s/ ANDERS HALLBERG
 
                    Name: Anders Hallberg
                    Title: Managing Director and CEO
 
                    HEALTHINVEST GLOBAL LONG/SHORT FUND
 
                    By: /s/ ANDERS HALLBERG
 
                    Name: Anders Hallberg
                    Title: CEO of Managing Company

Page 6 of  6 pages